Ajaykumar Chandrabhan Singh
YOU?
Author Swipe
View article: 82P Impact of compassionate access drugs in a low-middle income country such as India
82P Impact of compassionate access drugs in a low-middle income country such as India Open
Patients in a low-middle income country such as India do not have access to adequate clinical trials. Hence despite many newer drugs showing significant impact in cancer disease control in clinical trials they are not accessible to our pat…
View article: A Comparative Study Evaluating the Quality of Life and Survival Outcomes in Patients Receiving Chemotherapy Versus Oral Tyrosine Kinase Inhibitor in the Third Line and Beyond Setting for Advanced NSCLC
A Comparative Study Evaluating the Quality of Life and Survival Outcomes in Patients Receiving Chemotherapy Versus Oral Tyrosine Kinase Inhibitor in the Third Line and Beyond Setting for Advanced NSCLC Open
View article: 897P Nanosomal docetaxel lipid suspension (NDLS) or docetaxel based neoadjuvant therapy in Head and neck squamous cell carcinoma: Post hoc analysis of a prospective, randomized study
897P Nanosomal docetaxel lipid suspension (NDLS) or docetaxel based neoadjuvant therapy in Head and neck squamous cell carcinoma: Post hoc analysis of a prospective, randomized study Open
View article: Study of Treatment Outcome in Adults with TFE-Related RCC
Study of Treatment Outcome in Adults with TFE-Related RCC Open
Introduction TFE Translocation renal cell carcinoma (TRCC) represents 1 to 5% of all cases of renal cell carcinoma, with the highest frequency among children and young adults. Management of these tumors is not very well defined in literatu…